ArticleInvestigational new drugs2023

Predictive performance of PD-L1 tumor proportion score for nivolumab response evaluated using archived specimens in patients with non-small cell lung cancer experiencing a postoperative recurrence.

Yusuke Shima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.